Office of Rare Diseases Research
E93883
The Office of Rare Diseases Research is a U.S. government program that coordinates and supports research, information, and collaboration efforts focused on rare diseases.
All labels observed (2)
| Label | Occurrences |
|---|---|
| Office of Rare Diseases Research canonical | 1 |
| Rare Diseases Clinical Research Network | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T789408 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Office of Rare Diseases Research Context triple: [National Center for Advancing Translational Sciences, hasPart, Office of Rare Diseases Research]
-
A.
National Center for Advancing Translational Sciences
The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
-
B.
National Institute of Child Health and Human Development
The National Institute of Child Health and Human Development is a U.S. federal biomedical research institute that focuses on understanding human development, improving reproductive health, and enhancing the lives of children and families.
-
C.
National Human Genome Research Institute
The National Human Genome Research Institute is a U.S. government biomedical research organization that leads and funds research on the structure, function, and impact of the human genome.
-
D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
The National Institute of Arthritis and Musculoskeletal and Skin Diseases is a U.S. government biomedical research institute that conducts and supports research on arthritis, musculoskeletal disorders, and skin diseases.
-
E.
National Institute of General Medical Sciences
The National Institute of General Medical Sciences is a U.S. government biomedical research institute that supports fundamental, non-disease-specific science and training to advance understanding of biological processes and lay the groundwork for medical advances.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Office of Rare Diseases Research Target entity description: The Office of Rare Diseases Research is a U.S. government program that coordinates and supports research, information, and collaboration efforts focused on rare diseases.
-
A.
National Center for Advancing Translational Sciences
The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
-
B.
National Institute of Child Health and Human Development
The National Institute of Child Health and Human Development is a U.S. federal biomedical research institute that focuses on understanding human development, improving reproductive health, and enhancing the lives of children and families.
-
C.
National Human Genome Research Institute
The National Human Genome Research Institute is a U.S. government biomedical research organization that leads and funds research on the structure, function, and impact of the human genome.
-
D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
The National Institute of Arthritis and Musculoskeletal and Skin Diseases is a U.S. government biomedical research institute that conducts and supports research on arthritis, musculoskeletal disorders, and skin diseases.
-
E.
National Institute of General Medical Sciences
The National Institute of General Medical Sciences is a U.S. government biomedical research institute that supports fundamental, non-disease-specific science and training to advance understanding of biological processes and lay the groundwork for medical advances.
- F. None of above. chosen
Statements (50)
| Predicate | Object |
|---|---|
| instanceOf |
U.S. federal program
ⓘ
government office ⓘ |
| abbreviation | ORDR ⓘ |
| collaboratesWith |
Centers for Disease Control and Prevention
ⓘ
Food and Drug Administration ⓘ
surface form:
U.S. Food and Drug Administration
academic researchers ⓘ industry partners ⓘ other NIH institutes and centers ⓘ patient advocacy groups ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| establishedBy |
United States Congress
ⓘ
surface form:
U.S. Congress
|
| establishedInPeriod | 1990s ⓘ |
| field |
biomedical research
ⓘ
rare diseases ⓘ translational research ⓘ |
| focusesOn |
clinical trials for rare diseases
ⓘ
natural history studies of rare diseases ⓘ patient engagement in rare diseases ⓘ rare disease information dissemination ⓘ rare disease research coordination ⓘ rare disease research infrastructure ⓘ |
| hasMission |
to coordinate and support research on rare diseases
ⓘ
to foster collaboration among rare disease stakeholders ⓘ to provide information on rare diseases ⓘ |
| language | English ⓘ |
| legalBasis | Rare Diseases Act of 2002 ⓘ |
| locatedIn | Bethesda, Maryland ⓘ |
| movedTo | National Center for Advancing Translational Sciences ⓘ |
| movedToYear | 2011 ⓘ |
| operatedBy | National Institutes of Health ⓘ |
| parentOrganization |
National Institutes of Health
ⓘ
United States Department of Health and Human Services ⓘ
surface form:
U.S. Department of Health and Human Services
|
| partOf | National Center for Advancing Translational Sciences ⓘ |
| previouslyPartOf |
National Institutes of Health
ⓘ
surface form:
Office of the Director of the National Institutes of Health
|
| provides |
online information resources on rare diseases
ⓘ
resources for patient organizations ⓘ support for rare disease research networks ⓘ tools for rare disease registry development ⓘ |
| regulates | no, it is primarily a coordinating and supporting office ⓘ |
| sector | public health ⓘ |
| supportsProgram |
Genetic and Rare Diseases Information Center
ⓘ
Rare Diseases Clinical Research Network ⓘ Rare Diseases Registry Program ⓘ Toolkit for Patient-Focused Therapy Development ⓘ |
| targetAudience |
biomedical researchers
ⓘ
families and caregivers of rare disease patients ⓘ health care professionals ⓘ patients with rare diseases ⓘ policy makers ⓘ |
| website | https://rarediseases.info.nih.gov ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Office of Rare Diseases Research Description of subject: The Office of Rare Diseases Research is a U.S. government program that coordinates and supports research, information, and collaboration efforts focused on rare diseases.
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.
National Center for Advancing Translational Sciences
→
operates
→
Office of Rare Diseases Research
ⓘ
this entity surface form:
Rare Diseases Clinical Research Network